4.7 Article

Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study

期刊

LANCET INFECTIOUS DISEASES
卷 10, 期 12, 页码 835-844

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S1473-3099(10)70222-X

关键词

-

资金

  1. Department of Health, UK
  2. Department of Health
  3. UK Clinical Virology Network
  4. Encephalitis Society
  5. National Expert Panel on New and Emerging Infections
  6. Peel Medical Research Trust
  7. University College London Hospitals
  8. University College London Comprehensive Biomedical Research Centre of the National Institute for Health Research
  9. National Institute of Health Research, Department of Health
  10. National Institutes of Health Research (NIHR) [RP-PG-0108-10048] Funding Source: National Institutes of Health Research (NIHR)
  11. Medical Research Council [G116/194] Funding Source: researchfish
  12. National Institute for Health Research [RP-PG-0108-10048] Funding Source: researchfish
  13. MRC [G116/194] Funding Source: UKRI

向作者/读者索取更多资源

Background Encephalitis has many causes, but for most patients the cause is unknown. We aimed to establish the cause and identify the clinical differences between causes in patients with encephalitis in England. Methods Patients of all ages and with symptoms suggestive of encephalitis were actively recruited for 2 years (staged start between October, 2005, and November, 2006) from 24 hospitals by clinical staff. Systematic laboratory testing included PCR and antibody assays for all commonly recognised causes of infectious encephalitis, investigation for less commonly recognised causes in immunocompromised patients, and testing for travel-related causes if indicated. We also tested for non-infectious causes for acute encephalitis including autoimmunity. A multidisciplinary expert team reviewed clinical presentation and hospital tests and directed further investigations. Patients were followed up for 6 months after discharge from hospital. Findings We identified 203 patients with encephalitis. Median age was 30 years (range 0-87). 86 patients (42%, 95% CI 35-49) had infectious causes, induding 38 (19%, 14-25) herpes simplex virus, ten (5%, 2-9) varicella zoster virus, and ten (5%, 2-9) Mycobacterium tuberculosis; 75 (37%, 30-44) had unknown causes. 42 patients (21%, 15-27) had acute immune-mediated encephalitis. 24 patients (12%, 8-17) died, with higher case fatality for infections from M tuberculosis (three patients; 30%, 7-65) and varicella zoster virus (two patients; 20%, 2-56). The 16 patients with antibody-associated encephalitis had the worst outcome of all groups nine (56%, 30-80) either died or had severe disabilities. Patients who died were more likely to be immunocompromised than were those who survived (OR=3.44). Interpretation Early diagnosis of encephalitis is crucial to ensure that the right treatment is given on time. Extensive testing substantially reduced the proportion with unknown cause, but the proportion of cases with unknown cause was higher than that for any specific identified cause.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据